Seroprevalence of varicella zoster virus infections in Colombo District, Sri Lanka

Indian Journal of Medical Sciences

Volumn 61, Issue 3, 2007, Pages 128-134

  Liyanage, N P M ^a   Fernando, Sirimali ^a,b   Malavige, G N ^a   Mallikahewa, Ruvenika ^a   Sivayogan, S ^a   Jiffry, M T M ^a   Vitarana, Tissa ^a  

^a UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

^b National Science Foundation   (Sri Lanka)

Author keywords

Colombo; Seroprevalence; Varicella Zoster virus

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; CHILD; CLIMATE; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREGNANCY; RURAL POPULATION; SEROPREVALENCE; SRI LANKA; URBAN POPULATION; VARICELLA ZOSTER VIRUS;

EID: 33847777211     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.30747     Document Type: Article

References (30)

1. Losurdo G, Bertoluzzo L, Canale F, Timitilli A, Bondi E, Castagnola E, et al. Varicella and its complications as cause of hospitalization. Infez Med 2005;13:229-35.
2. Danovaro-Holliday MC, Gordon ER, Jumaan AO, Woernle C, Judy RH, Schmid DS, et al. High rate of varicella complications among mexican-born adults in alabama. Clin Infect Dis 2004;39:1633-9.
3. Ventura A. Varicella vaccination guidelines for adolescents and adults. Am Fam Physician 1997;55:1220-4.
4. Mohsen AH, Peck RJ, Mason Z, Mattock L, McKendrick MW. Lung function tests and risk factors for pneumonia in adults with chickenpox. Thorax 2001;56:796-9.
5. Vyse AJ, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect 2004;132:1129-34.
6. Khoshnood B, Debruyne M, Lancon F, Emery C, Fagnani F, Durand I, et al. Seroprevalence of varicella in the French population. Pediatr Infect Dis J 2006;25:41-4.
7. de Melker H, Berbers G, Hahne S, Rumke H, van den Hof S, de Wit A, et al. The epidemiology of varicella and herpes zoster in the Netherlands: Implications for varicella zoster virus vaccination. Vaccine 2006;24:3946-52.
8. Garnett GP, Cox MJ, Bundy DA, Didier JM, St Catharine J. The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiol Infect 1993;110:361-72.
9. Venkitaraman AR, John TJ. The epidemiology of varicella in staff and students of a hospital in the tropics. Int J Epidemiol 1984;13:502-5.
10. Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, et al. Age related seroprevalence of antibodies to varicella in India. Indian Pediatr 2000;37:714-9.
11. Ooi PL, Goh KT, Doraisingham S, Ling AE. Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian J Trop Med Public Health 1992;23:22-5.
12. Lolekha S, Tanthiphabha W, Sornchai P, Kosuwan P, Sutra S, Warachit B, et al. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg 2001;64:131-6.
13. Welgama U, Wickramasinghe C, Perera J. Varicella-zoster virus infection in the infectious diseases hospital, Sri Lanka. Ceylon Med J 2003;48:119-21.
14. Grose C. Varicella vaccination of children in the united states: Assessment after the first decade 1995-2005. J Clin Virol 2005;33:89-98.
15. Bidwell DE, Bartlett A, Voller A. Enzyme immunoassays for viral diseases. J Infect Dis 1977;136:S274-8.
16. Akram DS, Qureshi H, Mahmud A, Khan AA, Kundi Z, Shafi S, et al. Seroepidemiology of varicella-zoster in Pakistan. Southeast Asian J Trop Med Public Health 2000;31:646-9.
17. Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health 1998;3:886-90.
18. Burke BL, Steele RW, Beard OW, Wood JS, Cain TD, Marmer DJ. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982;142:291-3.
19. Miller AE. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 1980;30:582-7.
20. Jones L, Black AP, Malavige GN, Ogg GS. Persistent high frequencies of varicella-zoster virus orf4 protein-specific cd4+ t cells after primary infection. J Virol 2006;80:9772-8.
21. Malavige GN, Jones L, Black A, Ogg GS. Rapid effector function of varicella zoster virus glycoprotein I-specific cd4+ t cells many decades following primary infection. J Infect Dis 2006;194.
22. Hayward AR, Herberger M. Lymphocyte responses to varicella zoster virus in the elderly. J Clin Immunol 1987;7:174-8.
23. Corbeel L. Congenital varicella syndrome. Eur J Pediatr 2004;163:345-6.
24. Sasidharan CK, Anoop P. Congenital varicella syndrome. Indian J Pediatr 2003;70:101-3.
25. Katz VL, Kuller JA, McMahon MJ, Warren MA, Wells SR. Varicella during pregnancy. Maternal and fetal effects. West J Med 1995;163:446-50.
26. Yu HR, Huang YC, Yang KD. Neonatal varicella frequently associated with visceral complications: A retrospective analysis. Acta Paediatr Taiwan 2003;44:25-8.
27. Holmes CN. Predictive value of a history of varicella infection. Can Fam Physician 2005;51:60-5.
28. Heininger U, Baer G, Bonhoeffer J, Schaad UB. Reliability of varicella history in children and adolescents. Swiss Med Wkly 2005;135:252-5.
29. Kavaliotis J, Petridou S, Karabaxoglou D. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age. Int J Infect Dis 2003;7:274-7.
30. Christiansen D, Barnett ED. Comparison of varicella history with presence of varicella antibody in refugees. Vaccine 2004;22:4233-7.